In This Section

AACR To Host Inaugural AACR Oncology Industry Partnering Event, April 4-5

SAN DIEGO – The American Association for Cancer Research (AACR) will host the Inaugural AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients on April 4-5 at the San Diego Convention Center in San Diego, California. Media interested in covering the event can register for in-person or virtual attendance.

Held immediately prior to the AACR Annual Meeting 2024, this event will highlight the oncology pipelines and platforms of leading pharmaceutical and biotechnology companies as well as emerging scientific themes across the biopharmaceutical industry. With two full days of programming and networking, the event will bring researchers and industry partners together to share innovation strategies for drug development, and to present analysts and investors with new partnership and licensing opportunities to advance these concepts.


The three cochairs for the Inaugural AACR Oncology Industry Partnering Event are renowned experts in drug development and clinical research from academia, industry, and the investing community:

  • Michael A. Caligiuri, MD, FAACR, professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope; AACR Past President (2017-2018)
    • Read an interview with Caligiuri about the origins and goals of the event on the AACR’s blog.
  • Christiana Bardon, MD, MBA, comanaging partner, MPM | BioImpact Capital
  • William N. Hait, MD, PhD, FAACR, executive vice president, chief external innovation and medical officer, and member of the executive committee, Johnson & Johnson; AACR Past President (2007-2008) and Treasurer

The full event program is available on the AACR’s website, with confirmed presentations from:

  • Amgen
  • AstraZeneca
  • Bayer Pharmaceuticals
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Genentech: A Member of the Roche Group
  • Johnson & Johnson Innovative Medicine
  • Loxo@Lilly
  • Merck
  • Novartis
  • Pfizer
  • Takeda

Richard Pazdur, MD, director of the FDA’s Oncology Center of Excellence, will participate in a fireside chat with Alexander Gaffney, executive director of regulatory policy and intelligence at AgencyIQ by POLITICO, on Friday, April 5, at 1 p.m. PT.


Registration for the Inaugural AACR Oncology Industry Partnering Event is separate from registration for the AACR Annual Meeting 2024. Journalists who have already registered for the AACR Annual Meeting 2024 will need to register again for the Inaugural AACR Oncology Industry Partnering Event.

Journalists may register to attend the event in person in San Diego or virtually. To submit a request for complimentary media registration, please review the AACR’s media registration requirements and policies and fill out this form. Contact Kathleen Venango at [email protected] or 215-290-5408 with any registration questions.


For more information on the Inaugural AACR Oncology Industry Partnering Event, please contact a member of the AACR public relations team: